Related Experiment Video
Updated: May 31, 2026
07:32
Using Flow Cytometry to Detect and Quantitate Altered Blood Formation in the Developing Zebrafish
Published on: April 29, 2021
Zebrafish as a model for normal and malignant hematopoiesis
1Stem Cell Program and Division of Hematology/Oncology, Children's Hospital Boston and Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Disease Models & Mechanisms
|June 29, 2011
Summary
Zebrafish models are crucial for understanding blood disorders. Their genetic tractability and transparent embryos aid in studying hematopoiesis and developing new treatments for human blood diseases.
Area of Science:
- Hematology
- Developmental Biology
- Genetics
Background:
- Zebrafish have emerged as a key model organism in hematology research over the last 20 years.
- Their utility stems from efficient genetic and chemical screening capabilities.
- Transparent embryos facilitate in vivo imaging of blood development.
Purpose of the Study:
- To review methods for studying hematopoiesis in zebrafish.
- To summarize recent advancements in zebrafish hematology research.
- To highlight zebrafish's role in discovering drugs for blood disorders.
Main Methods:
- Large-scale genetic screening in zebrafish.
- Chemical screening for hematopoietic perturbations.
- In vivo imaging of embryonic hematopoiesis.
- Genetic manipulation of zebrafish embryos.
Main Results:
- Zebrafish studies have significantly advanced the understanding of hematopoiesis.
- Key genetic and chemical screens have identified novel regulators of blood development.
- In vivo imaging provides unprecedented insights into normal and aberrant hematopoiesis.
Conclusions:
- Zebrafish are invaluable for dissecting the mechanisms of hematopoiesis and blood disorders.
- This model system accelerates the discovery and development of therapeutic agents for human hematological conditions.
